Sodium tauroursodeoxycholate prevents paraquat-induced cell death by suppressing endoplasmic reticulum stress responses in human lung epithelial A549 cells-Reference-Cited by-同舟云学术

Sodium tauroursodeoxycholate prevents paraquat-induced cell death by suppressing endoplasmic reticulum stress responses in human lung epithelial A549 cells

Published:2013-03 Issue:4 Volume:432 Page:689-694
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Omura Tomohiro,Asari Masaru,Yamamoto Joe,Oka Kumiko,Hoshina Chisato,Maseda Chikatoshi,Awaya Toshio,Tasaki Yoshikazu,Shiono Hiroshi,Yonezawa Atsushi,Masuda Satohiro,Matsubara Kazuo,Shimizu Keiko

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference33 articles.

1. Paraquat poisoning. An overview of the current status;Bismuth;Drug Saf.,1990

2. Paraquat poisoning: clinical features and immediate general management;Vale;Hum. Toxicol.,1987

3. Role of antioxidants in paraquat toxicity;Suntres;Toxicology,2002

4. A literature review of paraquat toxicity;Onyeama;Vet. Hum. Toxicol.,1984

5. Apoptosis in human lung epithelial cells: triggering by paraquat and modulation by antioxidants;Cappelletti;Cell Biol. Int.,1998

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cetylpyridinium chloride triggers paraptosis to suppress pancreatic tumor growth via the ERN1-MAP3K5-p38 pathway;iScience;2024-08

2. Effects of Natural Products through Inhibiting Endoplasmic Reticulum Stress on Attenuation of Idiopathic Pulmonary Fibrosis;Drug Design, Development and Therapy;2024-05

3. UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis;Seminars in Liver Disease;2024-02

4. Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development;Pharmaceutics;2023-02-17

5. Signaling pathways involved in paraquat-induced pulmonary toxicity: Molecular mechanisms and potential therapeutic drugs;International Immunopharmacology;2022-12